Oligomycin frames a common drug-binding site in the ATP synthase

Area of Science:

• Biochemistry
• Structural Biology
• Molecular Biology

Background:

• Mitochondrial ATP synthase is crucial for cellular energy production.
• Oligomycin is a known inhibitor of ATP synthase, but its precise binding mechanism is not fully understood.
• Understanding inhibitor binding sites can guide the development of new therapeutic agents.

Purpose of the Study:

• To determine the high-resolution crystal structure of oligomycin bound to the yeast mitochondrial ATP synthase.
• To elucidate the molecular interactions responsible for oligomycin's inhibitory effect.
• To identify conserved drug-binding sites for potential antibiotic development.

Main Methods:

• High-resolution (1.9 Å) X-ray crystallography.
• Structural analysis of oligomycin-c(10) ring complex.
• Comparative analysis of binding site conservation between yeast, human, and bacterial homologs.

Main Results:

• The crystal structure reveals oligomycin binding to the surface of the yeast ATP synthase c(10) ring.
• Oligomycin binding inhibits ATP synthesis by interacting with key residues, including Glu59, essential for proton translocation.
• The identified binding site is highly conserved in humans but differs significantly from bacterial homologs, explaining differential drug sensitivity.

Conclusions:

• The structure provides a detailed molecular basis for oligomycin's inhibition of yeast mitochondrial ATP synthase.
• The conserved drug-binding site in yeast and human ATP synthases presents a potential target for novel antibiotic design.
• This finding could lead to the development of new drugs effective against pathogens like Mycobacterium tuberculosis.